Company profile
UK company 10649320, incorporated on 2 March 2017.
Spybiotech Limited is a UK company with status Active founded in 2017 based in South East England.
Company number 10649320
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
SpyBiotech was founded in March 2017 and employs researchers involved in vaccine development as well as a business development professional. The company is applying technology based on spontaneous isopeptide bond formation towards accelerating vaccine development for human disease. The principal technology is the SpyTag/SpyCatcher peptide/protein interaction but the company is also applying the orthogonal SnoopTag/SnoopCatcher and SnoopLigase systems. Advancement of protein assembly tools during the early stages of this grant has made a contribution to our understanding of evolution of spontaneous isopeptide bond formation.
SpyBiotech uses a biotechnology called superglue technology to develop and produce vaccines.
Vaccine development company
There are 6 full time equivalent posts employed at the company. The company is developing new vaccines and is currently doing pre-clinical testing and seeking to move towards clinical trials.
New labs, local employement, novel vaccine candidates in clinical development phase.
1 May 2023 to 30 Apr 2027
Malaria killed about 640 thousand people in 2020, largely young children in Africa. Rapid recent progress has led to two anti-sporozoite vaccine developers planning WHO prequalification applications in 2022. These include the new high efficacy R21/Matrix-M vaccine, to be supplied at the required large scale, and led by partners in this consortium. In para...
